Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
RXMD Down 26% from recent high - new Bear Trend!
After the current leg down re-visits $0.005
Load of bologna about the parent company. PharmCo is the consolidated entity. Armen is a real piece of work.. its easy to see how he lost his investment licenses to practice!
Ask Armen why he lost his FINRA license next time..
Looks like the Consultant paid in shares is dumping. So much for strong hands when DILUTION POLLUTION is underway - Lol!
Tomorrow RXMD Breaks Down Below 0.038 then Timber!
.039 is on the Bid.. Tomorrow .04s Break down!
Its just an obvious FACT..So much for fundamentals!
Your Shares are Currency to RXMD..
On December 1, 2015, the Company issued a bonus of 10,977,716 shares of common stock to the Company’s employees and executive management valued at $87,821.
On June 15, 2015, the Company engaged MIDAM Ventures, LLC to provided IR/PR consulting services. Under the terms of this agreement, the Company issued 20,000,000 shares of common stock, 10,000,000 shares on July 7, 2015 and 10,000,000 shares on November 24, 2015.
10,977,716 shares was approved by the Board of Directors and awarded to employees of PharmCo, LLC and Progressive Care Inc. Of these shares, 500,000 were awarded to Alan Jay Weisberg and 2,000,000 to Shital Parikh Mars.
On November 24, 2015, the Company issued 10,000,000 shares of its common stock to an outside consultant in consideration of $175,000 in consulting services/stock based compensation.
On August 20, 2015 the Company issued 6,083,985 shares of its common stock to an outside debtor in consideration of $150.000 loan to the company and $17,310 in accrued interest for a total consideration of $167,310.
During the Year Ended December 31, 2015 the company issued 273,913,000 shares of common stock to Tarpon Bay as part of the 3(a)(10) transaction.
Interest Expense was AFTER Operating Losses and the Robotic System, not yet in-place will add another $150K debt!
King of the OTC maybe right.. They've sold more shares than they authorized!
10-K (Pgs 26-27)..Current and Future Financing Needs
We have incurred an accumulated deficit of $3,419,896 through December 31, 2015 and $2,200,537 through December 31, 2014. We have spent, and expect to continue to spend, substantial amounts in connection with implementing our business strategy.
Based on our current plans, we believe that our current cash may not be sufficient to enable us to meet our planned operating needs. However, the actual amount of funds we will need to operate is subject to many factors, some of which are beyond our control. We have based our estimate on assumptions that may prove to be wrong. We may need to obtain additional funds sooner or in greater amounts than we currently anticipate. Potential sources of financing include public or private sales of our shares or debt and other sources. We may seek to access the public or private equity markets when conditions are favorable due to our long-term capital requirements. We do not have any committed sources of financing at this time and it is uncertain whether additional funding will be available when we need it on terms that will be acceptable to us, or at all. If we raise funds by selling additional shares of common stock or other securities convertible into common stock, the ownership interest of our existing stockholders will be diluted. If we are not able to obtain financing when needed, we may be unable to carry out our business plan. As a result, we may have to significantly limit our operations and our business, financial condition and results of operations would be materially harmed.
10-K (Pg 39)..During the year ended December 31, 2015, the Company had a net loss of approximately $1.219 million and negative cash flow from operations of approximately -$462,654. The Company does not believe that it will need additional capital to operate over the next 12 months but additional funding will be necessary to complete planned expansion initiatives. To address its financing requirements, the Company will seek funding through offering equity or convertible debt securities to individual and institutional investors. The outcome of these matters cannot be predicted at this time.
Historically, the Company has had operating losses, negative cash flows, and working capital deficiencies. Whether, and when, the Company can attain profitability and positive cash flows from operations is uncertain. Also, the Company is uncertain as to whether it can obtain financing to execute growth objectives.
No because their revenues lead to losses, they're nowhere near break-even.
Reason 'strong longs" in RXMD don't matter..
The company increased (ie: diluted) shares by 5X last year using the funds to pay off bills and debt. Now they want to expand with dilution going forward. This will cause a massive selloff of newly printed shares, so the percentage longs hold will be massively reduced. This is what you people don't get.
I wouldn't touch RXMD knowing their plans for dilutive growth. Besides the technicals (as I stated previously), are pointing to $0.0175. I'm short this stock, I earned a meager $1500 going long 150K, but the downside looks much jucier thank you!
Its obvious that RXMD is a Stinky Pinky, their Fins Prove it - Lol!
Dilution is the only available path to growth for RXMD..
10-K (Pg 39)..During the year ended December 31, 2015, the Company had a net loss of approximately $1.219 million and negative cash flow from operations of approximately -$462,654. The Company does not believe that it will need additional capital to operate over the next 12 months but additional funding will be necessary to complete planned expansion initiatives.To address its financing requirements, the Company will seek funding through offering equity or convertible debt securities to individual and institutional investors. The outcome of these matters cannot be predicted at this time.
Historically, the Company has had operating losses, negative cash flows, and working capital deficiencies. Whether, and when, the Company can attain profitability and positive cash flows from operations is uncertain. Also, the Company is uncertain as to whether it can obtain financing to execute growth objectives.
Uncertainties also exist as to the final outcome of legal proceedings which may entail a foreclosure on assets pledged by the Company, and settlement of these matters on beneficial terms for the Company is not assured. See Note 10.
These uncertainties cast significant doubt upon the Company’s ability to continue as a going concern. The Company’s financial statements do not include any adjustments that might result from the outcome of these uncertainties. See Note 10.
They also clearly state that growth will be DILUTIVE to existing shareholders! They have no other means to do it, they cannot get bank financing because they have no clear assets with which to back a loan. They're upside-down still with Negative Equity!
Just read the P&L (Pg 30).. At the Operational level (DUE TO SG&A EXPENSES ONLY), they lost $612,825. This is BEFORE EXTRAORDINARY AND ONE-TIME ITEMS!
And Mgmt lied to you.. They were NOT PROFITABLE even at the Operational Level! They spent way too much on SG&A.
Sounds like a typical OTC stock to me.. Selling shares for Cash! Dilution for the past year was 5X..
2014 shares O/S were 31,338,602
2015 shares O/S were 155,613,592
HoHoHo!
10-K (Pg 19)..We will seek to raise additional funds in the future, which may be dilutive to stockholders or impose operational restrictions.
We expect to seek to raise additional capital in the future to help fund development of our proposed expansion. If we raise additional capital through the issuance of equity or convertible debt securities, the percentage ownership of our current stockholders will be reduced. We may also enter into strategic transactions and/or compensate consultants or
settle outstanding payables using equity that may be dilutive. Our stockholders may experience additional dilution in net book value per share and any additional equity securities may have rights, preferences and privileges senior to those of the holders of our common stock. If we cannot raise additional funds, we will have to delay development activities of our expansion plans
10-K (Pg 25)..Net loss from continuing operations increased 43.50% for the year ended December 31, 2015 as compared to the year ended December 31, 2014, from approximately $.43 million to approximately $0.61 million. Total net loss increased 21% for the year ended December 31, 20145 as compared to the year ended December 31, 2014 from approximately $1 million to approximately $1.2 million. This increase in net loss was substantially due increases in operating expenses as a result of expansion initiatives, losses on debt settlement and recorded losses on the discontinuation of PharmCo,780.
Red, utilities are only variable costs for industries in manufacturing wherein the more revenues are produced, the more utilties are used in manufacturing. For a pharmacy, utility expense is fixed (ie: not dependent on how many prescriptions are filled in the allotted store hours open. So variable and fixed differ depending on the industry. Rent would be a fixed cost for both a manufacturing and a pharmacy operation as its fixed and doesn't increase with increased revenues. This is what variable means, to vary with revenue production.
You're confused with EBIT.. Earnings Before Interest & Taxes. Operating profit is aligned with variable expenses against Revenues.
Arman Karapetyan, an Officer of RXMD Forced to Forfeit Securities License..
"On September 28, 2012, Armen Karapetyan agreed to an offer of settlement from FINRA, an SRO, without admission of any wrongdoing to voluntarily forfeit his securities licensure and accept permanent bar from engaging in securities activities at a broker dealer. This agreement was made after allegations of violations of various securities rules and laws."
From Supplemental Information supplied on Aug 6, 2015
Beware the Slow Stoch Death Cross first!
Great Management like Armen? - LOL!
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=121423146
It won't stop at $0.03, no support until $.02s ($0.0175 - $0.025)
No, if they want their margin they ask for Gross Profit Percentage.
"Gross Margin is often used interchangeably as Gross Profit"
$0.041 will Break to the Downside Fast to $0.03
Operating Income is Revenue - Variable Expenses.. Google it!
Wrong again.. Revenue less COGS = Gross Margin
They're only talking about their variable costs. Add in the rest of the costs (fixed expenses) and you end up with a loss. Operating income is Revenue less variable costs only! Management is deceiving and setting you guys up for the Fall!
Lies.. RXMD still owes 2X their Assets and they're still losing $$
Looks like all the Power will be to the Downside..
Best Brokerage is Just2Trade for $2.50 a trade..